IBEC researcher in first class of d·HEALTH Barcelona
IBEC senior researcher Mateu Pla is one of the first class of just 12 fellows chosen for the first Design Health Barcelona (d·HEALTH Barcelona) higher education programme, which starts this week.
IBEC senior researcher Mateu Pla is one of the first class of just 12 fellows chosen for the first Design Health Barcelona (d·HEALTH Barcelona) higher education programme, which starts this week.
Josep A. Planell, founding director of IBEC, was presented with the European Society of Biomaterials’ prestigious George Winter prize at their annual conference held in Madrid on Tuesday.
IBEC researchers have come up with a groundbreaking new approach to create a tough, biodegradable, bioactive and entirely new material, heralding a major milestone in the production of artificial matrices for tissue engineering.In a letter published today in the Royal Society journal Interface, the Biomaterials for Regenerative Therapies group describes a new, easy and cheap method for producing glass-coated fibrous scaffolds which not only faithfully mimic the extracellular matrix of bone, but also aim to direct stem cell fate through physical and chemical interactions.
The latest cover of the respected chemistry journal Angew Chem features the Nanoprobes and Nanoswitches group’s paper, released online last month, that describes a strategy to quickly and reversibly impair the function of specific proteins using light-regulated inhibitory peptides. As well as being chosen for the cover, their paper was among the 5% to be included in the ‘Very Important Paper’ section of the journal, and has also been extensively publicised in the press both here and abroad.
Control of stem cell potency group leader Ángel Raya appeared on Thursday night’s edition of current events programme Barcelona Connexió on Barcelona Televisió (BTV), in a special report on cloning.